Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lymphoma, Mantle-Cell × venetoclax × Clear all

Phase

Status

Completed 9 Recruiting 6 Terminated 5 Active not recruiting 5 Withdrawn 1 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 19 Leukemia, Lymphocytic, Chronic, B-Cell 2 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1

Interventions

Cyclophosphamide 15 Rituximab 12 Cytarabine 8 Peripheral Blood Stem Cell Transplantation 7 Melphalan 6 Filgrastim 6 Etoposide 6 fludarabine phosphate 5 fludarabine 5 Radiotherapy 5 Dexamethasone 5 Cyclosporine 5 ibrutinib 4 Lenalidomide 4 Carmustine 4 Bortezomib 4 Vincristine 3 Sensitivity and Specificity 3 Prednisone 3 Mycophenolic Acid 3 Interferon-alpha 3 Indium 3 Doxorubicin 3 Busulfan 3 Bendamustine Hydrochloride 3 Antilymphocyte Serum 3 Antigens, CD19 3 orelabrutinib 2 epratuzumab 2 Radioimmunodetection 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471391 2023-08-21

AIM

Peter MacCallum Cancer Centre, Australia

Phase 2 Unknown

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡